Cargando…
Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma
Integration of morphological, immunohistochemical and molecular methods is often necessary for the precise diagnosis and optimal clinical management of sarcomas. We have validated and implemented a clinical molecular diagnostic assay, MSK-Fusion Solid, for detection of gene fusions in solid tumors i...
Autores principales: | Zhu, Guo, Benayed, Ryma, Ho, Caleb, Mullaney, Kerry, Sukhadia, Purvil, Rios, Kelly, Berry, Ryan, Rubin, Brian P., Nafa, Khedoudja, Wang, Lu, Klimstra, David S., Ladanyi, Marc, Hameed, Meera R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6486453/ https://www.ncbi.nlm.nih.gov/pubmed/30459475 http://dx.doi.org/10.1038/s41379-018-0175-7 |
Ejemplares similares
-
Pseudomyogenic hemangioendothelioma of bone with rare WWTR1‐FOSB fusion gene: Case report and literature review
por: Murshed, Khaled A., et al.
Publicado: (2021) -
Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics
por: Sugita, Shintaro, et al.
Publicado: (2016) -
Clinicopathological study of pseudomyogenic hemangioendothelioma
por: Yang, Ningning, et al.
Publicado: (2023) -
Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma
por: Joseph, Jason, et al.
Publicado: (2015) -
A Case of Pseudomyogenic Hemangioendothelioma of the Lower Extremity
por: Choi, Myoung Eun, et al.
Publicado: (2020)